Effect of adipose derived stromal vascular fraction on leprosy neuropathy: A Preliminary report
Authors: Sondang P Sirait, Kusmarinah Bramono, Sri Linuwih Menaldi, Jeanne Adiwinata Pawitan, Wresti Indriatmi, Tiara Aninditha
Journal: PLOS Neglected Tropical Diseases
Accepted: 2022-11-30T00:00:00Z

Background: Adipose derived stromal vascular fraction (SVF) contains a heterogeneous population of mononuclear cells, progenitor cells and about 1–10% are mesenchymal stromal cells. These cells are an ideal candidate for regenerative medicine for peripheral neuropathy. Leprosy is a disabling disorder with neuropathy, usually with consequences of permanent disability of the extremities. We conducted a preliminary study to evaluate the cell yield, its characteristics and clinical outcomes after SVF injections in four leprosy patients. Methods: Four post leprosy patients were recruited and evaluated for sensory testing (warm detection, cold detection, vibration, pain and sensation) on the ulnar area of the hand. Liposuction was done and adipose tissue was processed into SVF with a closed system and injected to the ulnar area of the hand at the dorsal and palmar side. Evaluation of sensory testing was done after 3 days, 1 week, 1 month and 3 months following SVF injection. SVF was also characterized using flow cytometry, cell counting, sterility and presence of mycobacteria. Results: The results showed that leprosy patients had a low count of mesenchymal cells and a high amount of CD34/CD45 positive cells. One patient was positive for mycobacteria from his adipose tissue and SVF. Sensory examination after SVF injection showed an improvement in temperature and pain sensation in the palmar and superficial branch. Meanwhile, touch sensation improved on the dorsal branch, and there was no improvement for vibration in all patients. Conclusions: The results showed that SVF had a potential to improve sensory loss in leprosy patients. Author summary: Leprosy is an infectious disease caused by M. leprae bacteria. Generally, this disease infects the skin and peripheral nerves. Most of the leprosy cases treatment is delayed, which causes nerve impairment and permanent disability. Sensory ulnar nerve impairment is the most common disability found in leprosy. Earliest signs that could be observed are paresthesia or anesthesia and unable to perceive other sensations. Permanent disability in leprosy cases usually leads to negative stigma and isolation of the patients. Thus, the treatment for nerve impairment has been one of the WHO global leprosy strategy. Adipose tissue were known as source of stem cells and could be processed to be used as a injected treatment, in the form of stromal vascular fraction (SVF). These cells could develop into many kinds of cells, including nerve cells, while also repairing the impaired cells. However, currently there are no available studies on SVF treatment for nerve impairment caused by leprosy. Therefore, this preliminary study aims to determine whether SVF cells of leprosy patients could be used as treatment for nerve impairment caused by leprosy. We report 4 post leprosy patients who underwent SVF injection intradermally on their ulnar area of the hand, with promising results.